Keywords
Genetic heart disease
Gene mutation
Whole exome sequencing
Submitted : 2026-04-20
Accepted : 2026-05-05
Published : 2026-05-20
Abstract
Objective: To explore the etiology of a typical case of unexplained sudden death in Yunnan (referred to as “Yunnan sudden death”), correlate genotypes with phenotypes to identify high-risk populations, and provide a basis for intervention measures. Methods: Epidemiological and clinical investigation data, as well as blood biochemical test results, were collected from three cases of Yunnan sudden death. Whole exome sequencing (WES) was performed on blood samples, using GRCh38/HG19 as the reference sequence. Mutation sites were screened based on genetic heart disease-related gene variants and subjected to filtering, annotation, and analysis. Protein function prediction analysis of mutated genes was conducted using SIFT, Mutation Taster, and PolyPhen2 software. Results: After screening, harmful and ambiguous mutation sites were retained, involving 18 mutation site information from four genetic heart disease-related genes (DMD, SIDT1, CSRP3, DSG2). Among them, 17 were predicted by software to have harmful, harmful, or pathogenic protein functions. Deceased 2 carried six mutation sites in DMD, deceased 2 and deceased 4 jointly carried nine mutation sites in SIDT1, and deceased 3 carried two mutation sites in CSRP3. Conclusion: The causes of death in the three cases of Yunnan sudden death in this study are highly likely related to mutations in genetic heart disease-related genes.
References
Cheng X, Wang Y, 2023, Research Progress on the Etiology of Unexplained Sudden Death in Yunnan. Chinese Journal of Endemiology, 42(5): 426–430.
Cheng X, 2024, Study on the Etiological Relationship Between Unexplained Sudden Death in Yunnan and ARVC Desmosomal Protein Gene Mutations, thesis, Dali University.
Liu Y, Wang Y, Xi Y, et al., 2024, Analysis of Electrocardiogram and Echocardiogram Examinations in the Population in Key Affected Areas of Unexplained Sudden Death in Yunnan. Chinese Journal of Endemiology, 43(3): 81–85.
Wang Y, Shen T, Shi G, et al., 2013, Electrocardiogram Investigation in the Population in Key Affected Areas of Unexplained Sudden Death in Yunnan. Disease Prevention and Control Bulletin, 2013(6): 9–12.
Webster G, Puckelwartz M, Pesce L, et al., 2021, Genomic Autopsy of Sudden Deaths in Young Individuals. JAMA Cardiology, 6(11): 1247–1256.
Li L, Wang Y, Qu P, et al., 2020, Genetic Analysis of Yunnan Sudden Unexplained Death by Whole Genome Sequencing in Southwest of China. Journal of Forensic and Legal Medicine, 70: 101896.
Jia P, Wang Y, Fu H, et al., 2018, Postmortem Analysis of 4 Mutation Hotspots of KCNQ1, KCNH2, and SCN5A Genes in Sudden Unexplained Death in Southwest of China. The American Journal of Forensic Medicine and Pathology, 39(3): 218–222.
Wang Y, Xu Y, Zhou C, et al., 2024, Exome Sequencing Reveals Genetic Heterogeneity and Clinically Actionable Findings in Children with Cerebral Palsy. Nature Medicine, 30(5): 1395–1405.
Nurchis M, Radio F, Salmasi L, et al., 2024, Cost-Effectiveness of Whole-Genome vs Whole-Exome Sequencing Among Children with Suspected Genetic Disorders. JAMA Network Open, 7(1): e2353514.
Hua C, Liu L, Yang S, et al., 2024, Zhonghua Er Ke Za Zhi. Chinese Journal of Pediatrics, 62(2): 153–158.
Mavrogeni S, Markousis-Mavrogenis G, Papavasiliou A, et al., 2015, Cardiac Involvement in Duchenne and Becker Muscular Dystrophy. World Journal of Cardiology, 7(7): 410–414.
Nakamura A, 2015, X-Linked Dilated Cardiomyopathy: A Cardiospecific Phenotype of Dystrophinopathy. Pharmaceuticals, 8(2): 303–320.
Fortunato F, Farnè M, Ferlini A, 2021, The DMD Gene and Therapeutic Approaches to Restore Dystrophin. Neuromuscular Disorders, 31(10): 1013–1020.
Shigemizu D, Aiba T, Nakagawa H, et al., 2015, Exome Analyses of Long QT Syndrome Reveal Candidate Pathogenic Mutations in Calmodulin-Interacting Genes. PLoS One, 10(7): e0130329.
Mohapatra B, Jimenez S, Lin J, et al., 2003, Mutations in the Muscle LIM Protein and Alpha-Actinin-2 Genes in Dilated Cardiomyopathy and Endocardial Fibroelastosis. Molecular Genetics and Metabolism, 80(1–2): 207–215.
Huang H, Chen Y, Jin J, et al., 2022, CSRP3, p.Arg122*, Is Responsible for Hypertrophic Cardiomyopathy in a Chinese Family. Journal of Gene Medicine, 24(1): e3390.
Maron B, Maron M, 2013, Hypertrophic Cardiomyopathy. Lancet, 381(9862): 242–255.
Kogut J, Popjes E, 2020, Hypertrophic Cardiomyopathy 2020. Current Cardiology Reports, 22(11): 154.
Sun L, Li J, Li E, et al., 2020, CRISPR/Cas9 Mediated Establishment of a Human CSRP3 Compound Heterozygous Knockout hESC Line to Model Cardiomyopathy and Heart Failure. Stem Cell Research, 49: 102077.
Krahn A, Wilde A, Calkins H, et al., 2022, Arrhythmogenic Ventricular Cardiomyopathy. JACC Clinical Electrophysiology, 8(4): 533–553.
Qiu Z, Zhao Y, Tao T, et al., 2022, Activation of PPARα Ameliorates Cardiac Fibrosis in Dsg2-Deficient Arrhythmogenic Cardiomyopathy. Cells, 11(20): 3184.
Stafford F, Krishnan N, Richardson E, et al., 2022, The Role of Genetic Testing in Diagnosis and Care of Inherited Cardiac Conditions in a Specialised Multidisciplinary Clinic. Genome Medicine, 14(1): 145.
Moulson N, Isserow S, McKinney J, 2022, Lifestyle Considerations in Genetic Cardiac Conditions Associated with Sudden Cardiac Death. Canadian Journal of Cardiology, 38(4): 544–548.
van den Heuvel L, van Teijlingen M, van der Roest W, et al., 2020, Long-Term Follow-Up Study on the Uptake of Genetic Counseling and Predictive DNA Testing in Inherited Cardiac Conditions. Circulation: Genomic and Precision Medicine, 13(5): 524–530.